Navigation Links
Oticon Tapes Out Innovative Hearing-Aid DSP Using Synopsys IC Compiler
Date:6/2/2008

IC Compiler Enables Extremely Low-Power Design for Innovative Medical

Device

MOUNTAIN VIEW, Calif., June 2 /PRNewswire-FirstCall/ -- Synopsys, Inc. (Nasdaq: SNPS), a world leader in software and IP for semiconductor design and manufacturing, today announced that Oticon has taped out part of its next-generation digital signal processor (DSP) chipset for hearing-aid devices using Synopsys' IC Compiler design planning and place-and-route product, which is part of the Eclypse(TM) Low Power Solution. Enhanced design productivity, small form factor, and low power consumption were key requirements for Oticon's design. Oticon leveraged IC Compiler within Synopsys' Pilot Design Environment, delivering predictable low-power results and enabling faster time to tapeout.

"Battery life is one of our customers' major concerns. Taking advantage of IC Compiler's automatic multi-voltage, MTCMOS shutdown, and multi-threshold capabilities, we were able to meet our extreme low-power requirements and deliver new innovation to our hearing aid users," said Mogens Balsby, director of IC Design at Oticon. "Because we were moving to a new, advanced technology node and time-to-market was critical, we used Synopsys' Pilot tapeout-proven design environment, which includes full implementation, formal checking, and physical verification and leverages best-in-class tools. We were extremely satisfied with the results achieved with IC Compiler and the Pilot Design Environment on our complex design."

Oticon is the world leader in the design, development, and manufacture of hearing aids that embed sophisticated integrated circuits (ICs) that deliver massively parallel, digital audio signal processing and wireless communication. The new DSP's breakthrough real-time wireless technology enables two hearing aids to work together to process sound, similar to the way the brain receives input from two ears, to deliver three-dimensional auditory information that enhances the user's listening experience.

"IC Compiler's automated low-power optimization technology was instrumental in helping Oticon meet its low-power requirements, and Synopsys' Pilot Design Environment enabled them to complete their tapeout on schedule," said Antun Domic, senior vice president and general manager of Synopsys' Implementation Group. "As Oticon continues creating innovative products for their customers, it can leverage more of the advanced capabilities in IC Compiler, such as concurrent hierarchical design, for further product differentiation and faster time-to-results."

About IC Compiler

IC Compiler is Synopsys' comprehensive physical design solution. It provides superior results and faster time-to-results by extending physical synthesis to full place-and-route, and by enabling signoff-driven design closure. Older solutions have a limited horizon because placement, clock tree, and routing are separate, disjointed operations. IC Compiler's XPS technology breaks down the walls between these steps by extending physical synthesis to full place-and-route. IC Compiler has a unified, TCL-based architecture that implements innovations and harnesses some of Synopsys' best core technologies. It is a comprehensive physical design system with the features necessary to implement next-generation designs, including physical synthesis, design planning, placement, routing, timing, signal integrity (SI) optimization, power reduction, design-for-test (DFT), and yield optimization.

IC Compiler is part of the Eclypse Low Power Solution, which is a comprehensive alignment of low power design and verification technologies, IP, methodologies and services built on industry standards.

About Synopsys

Synopsys, Inc. (NASDAQ:SNPS) is a world leader in electronic design automation (EDA), supplying the global electronics market with the software, intellectual property (IP) and services used in semiconductor design and manufacturing. Synopsys' comprehensive, integrated portfolio of implementation, verification, IP, manufacturing and field-programmable gate array (FPGA) solutions helps address the key challenges designers and manufacturers face today, such as power and yield management, system-to-silicon verification and time-to-results. These technology-leading solutions help give Synopsys customers a competitive edge in bringing the best products to market quickly while reducing costs and schedule risk. Synopsys is headquartered in Mountain View, California, and has more than 60 offices located throughout North America, Europe, Japan, Asia and India. Visit Synopsys online at http://www.synopsys.com/.

Synopsys and Eclypse are registered trademarks or trademarks of Synopsys, Inc. Any other trademarks or registered trademarks mentioned in this release are the intellectual property of their respective owners.

Sheryl Gulizia

Synopsys, Inc.

650-584-8635

sgulizia@synopsys.com

Lisa Gillette-Martin

MCA, Inc.

650-968-8900 ext. 115

lgmartin@mcapr.com


'/>"/>
SOURCE Synopsys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eric Rowinsky, M.D. and Martin Cannon Join Tapestry Board of Directors
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
3. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
4. Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference
5. Riverside Partners Teams with Management to Acquire Innovative Product Achievements
6. TriWest Receives National Awards for Innovative Video Communications to Military Community
7. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
8. Innovative antennae may signal a new wave in health care provision
9. Beautiful Teeth Not Just for the Dentists Office Anymore / SpaBrite Teeth Whitening System(TM) Introduces Innovative, New Teeth Whitening Experience To Spas
10. Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors
11. In blood vessel stents, innovative materials allow better control, delivery of gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology: